While the hype around Tonix Pharmaceuticals at the moment has to do with its development of a COVID-19 skin test, I believe the real value in the company lies in its late-stage studies in fibromyalgia and PTSD, with TNX-102 SL being the real value here. Not to mention the drug’s potential ability to treat patients with Alzheimer’s disease and alcohol use disorder are the icing on the cake.
83M traded already...the chart looks ready to go higher...$2 at least. Price target anyone? Does this stock have coverage from any analysts? I see some supposed targets of $3 or so on Yahoo...but no one has initiated anything new in over 1-2 yrs. Hmmm...thoughts?